Sustained intraocular delivery of nintedanib via PLGA implant eradicates pathological angiogenesis in retinal neovascularization

No abstract is available for this paper.

• Publication year

  2026

• Venue

  Journal of Drug Delivery Science and Technology

• Publication date

  2026-01-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1016/j.jddst.2025.107820
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• A novel model of subretinal edema induced by DL-alpha aminoadipic acid.

  2023cited by this paper
• Solubility Measurement and Thermodynamic Properties of Nintedanib Esylate Hemihydrate in Pure Solvents

  2022cited by this paper
• Recent Progress in Drug Release Testing Methods of Biopolymeric Particulate System

  2021cited by this paper
• An Effective Interface Tracking Method for Simulating the Extrudate Swell Phenomenon

  2021cited by this paper
• Inhibition of ocular neovascularization by novel anti-angiogenic compound.

  2021cited by this paper
• Enhanced oral bioavailability of nintedanib esylate with nanostructured lipid carriers by lymphatic targeting: in vitro, cell line and in vivo evaluation.

  2021cited by this paper
• Long-term multimodal imaging characterization of persistent retinal neovascularization using DL-alpha-aminoadipic acid in pigmented and white rabbits.

  2021cited by this paper
• An allosteric peptide inhibitor of HIF-1α regulates hypoxia-induced retinal neovascularization

  2020cited by this paper
• Critical analysis of techniques and materials used in devices, syringes, and needles used for intravitreal injections.

  2020cited by this paper
• Long-term safety and tolerability of nintedanib in patients with idiopathic pulmonary fibrosis: results from the open-label extension study, INPULSIS-ON.

  2019cited by this paper
• 3D printing of a poly(vinyl alcohol)-based nano-composite hydrogel as an artificial cartilage replacement and the improvement mechanism of printing accuracy.

  2019cited by this paper
• Improving The Oral Absorption Of Nintedanib By A Self-Microemulsion Drug Delivery System: Preparation And In Vitro/In Vivo Evaluation

  2019cited by this paper
• Anti-VEGF therapy: higher potency and long-lasting antagonism are not necessarily better.

  2019cited by this paper
• Clinical Pharmacokinetics and Pharmacodynamics of Nintedanib

  2019cited by this paper
• Melatonin attenuated retinal neovascularization and neuroglial dysfunction by inhibition of HIF‐1α‐VEGF pathway in oxygen‐induced retinopathy mice

  2018cited by this paper
• Panretinal Photocoagulation: A Review of Complications

  2018cited by this paper
• A novel model of persistent retinal neovascularization for the development of sustained anti‐VEGF therapies

  2018cited by this paper
• Effects of formulation composition on the characteristics of mucoadhesive films prepared by hot‐melt extrusion technology

  2018cited by this paper
• Population pharmacokinetics of nintedanib, an inhibitor of tyrosine kinases, in patients with non-small cell lung cancer or idiopathic pulmonary fibrosis

  2017cited by this paper
• Diabetic macular oedema.

  2017cited by this paper
• Nanoemulsion‐based electrolyte triggered in situ gel for ocular delivery of acetazolamide

  2017cited by this paper
• Mechanisms of in vivo release of triamcinolone acetonide from PLGA microspheres

  2017cited by this paper
• Systemic Safety of Prolonged Monthly Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema: A Systematic Review and Meta-analysis.

  2016cited by this paper
• Management of Neovascular Age-related Macular Degeneration: A Review on Landmark Randomized Controlled Trials

  2016cited by this paper
• Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.

  2015cited by this paper
• Self-healing of pores in PLGAs.

  2015cited by this paper
• Non-invasive in vivo characterization of microclimate pH inside in situ forming PLGA implants using multispectral fluorescence imaging.

  2014cited by this paper
• Targeting neovascularization in ischemic retinopathy: recent advances

  2013cited by this paper
• Diabetic retinopathy.

  2012cited by this paper
• A Review of Hot-Melt Extrusion: Process Technology to Pharmaceutical Products

  2012cited by this paper
• Physical and sensory characteristics of extruded snacks prepared from Foxtail millet based composite flours

  2011cited by this paper
• BIBF 1120: triple angiokinase inhibitor with sustained receptor blockade and good antitumor efficacy.

  2008cited by this paper
• Effect of acidic pH on PLGA microsphere degradation and release.

  2007cited by this paper
• Age-related macular degeneration.

  2006cited by this paper
• Vascular endothelial growth factor receptors: molecular mechanisms of activation and therapeutic potentials.

  2006cited by this paper
• How porosity and size affect the drug release mechanisms from PLGA-based microparticles.

  2006cited by this paper
• How autocatalysis accelerates drug release from PLGA-based microparticles: a quantitative treatment.

  2005cited by this paper
• Determination of water-soluble acid distribution in poly(lactide-co-glycolide).

  2004cited by this paper
• Cell Type–Specific Regulation of Angiogenic Growth Factor Gene Expression and Induction of Angiogenesis in Nonischemic Tissue by a Constitutively Active Form of Hypoxia-Inducible Factor 1

  2003cited by this paper
• Characterization of the initial burst release of a model peptide from poly(D,L-lactide-co-glycolide) microspheres.

  2002cited by this paper
• In-vitro studies of diclofenac sodium controlled-release from biopolymeric hydrophilic matrices.

  2002cited by this paper
• Retinopathy of prematurity: recent advances in our understanding

  2002cited by this paper
• Analysis of Fickian and non-Fickian drug release from polymers.

  1985cited by this paper
• Interpretation of percent dissolved-time plots derived from in vitro testing of conventional tablets and capsules.

  1969cited by this paper
• MECHANISM OF SUSTAINED-ACTION MEDICATION. THEORETICAL ANALYSIS OF RATE OF RELEASE OF SOLID DRUGS DISPERSED IN SOLID MATRICES.

  1963cited by this paper

• No citing papers are available for this paper.